Fulcrum Therapeutics
FULC
FULC
101 hedge funds and large institutions have $197M invested in Fulcrum Therapeutics in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 40 increasing their positions, 22 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
24% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 25
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
79% less capital invested
Capital invested by funds: $918M → $197M (-$721M)
Holders
101
Holding in Top 10
2
Calls
$4.55M
Puts
$350K
Top Buyers
1 | +$8.15M | |
2 | +$4.66M | |
3 | +$3.64M | |
4 |
BlackRock
New York
|
+$2.09M |
5 |
RI
RTW Investments
New York
|
+$1.72M |
Top Sellers
1 | -$16.7M | |
2 | -$8.23M | |
3 | -$5.6M | |
4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$5.43M |
5 |
CAC
Cowen and Company
New York
|
-$5.23M |